Soluble amyloid precursor protein β as blood-based biomarker of Alzheimer's disease

@inproceedings{Perneczky2013SolubleAP,
  title={Soluble amyloid precursor protein β as blood-based biomarker of Alzheimer's disease},
  author={Robert Perneczky and L-H Guo and Simone M. Kagerbauer and Lukas Werle and Alex Kurz and Jean F Martin and Panagiotis Alexopoulos},
  booktitle={Translational Psychiatry},
  year={2013}
}
The aim of this study was to explore concentrations differences of soluble amyloid precursor protein (sAPP) α and β in blood plasma in patients with probable Alzheimer’s disease (AD) and cognitively healthy age-matched control subjects, as well as patients with behavioural variant frontotemporal dementia (bvFTD). Concentrations of sAPPα and β were measured using enzyme-linked immunosorbent assay technology in 80 patients with probable AD, 37 age-matched control subjects and 14 patients with… CONTINUE READING